Who is sponsoring NCT05668507?

NCT05668507 is sponsored by University of British Columbia.

What drugs are being tested in NCT05668507?

Interventions in NCT05668507: REACHOUT Virtual Mental Health Support.

What condition does NCT05668507 study?

NCT05668507 studies Type1diabetes.

Is NCT05668507 still recruiting?

NCT05668507 is currently active, enrolled. Last updated 13 November 2024.

Last reviewed 2024-11-13 · How we verify

NCT05668507

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

REACHOUT Mental Health Support Mobile App

Active, enrolled NA Last updated 13 November 2024

What this trial tests

NA trial testing REACHOUT Virtual Mental Health Support in Type1diabetes in 225 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 January 2024

Primary endpoint
25 April 2025

25 April 2025

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	225
Start date	15 January 2024
Primary completion	25 April 2025
Estimated completion	25 April 2025
Sites	1 location across Canada

Drugs / interventions tested

REACHOUT Virtual Mental Health Support

Conditions studied

Type1diabetes — all drugs for Type1diabetes →

Sponsor

University of British Columbia

Who can join

19 and older, any sex, with Type1diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effectiveness of participation in a 6-month peer-led mental health support program, delivered via a mobile app (REACHOUT), to adults with type 1 diabetes compared to a wait-list control condition. Participants will connect with a Peer-Supporter (an adult with type 1 diabetes trained in providing mental health support), and have access to the app features including a 24/7 chat room and face-to-face support delivered via virtual happy hours.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

T1D REACHOUT-A Mobile App to Deliver Peer-Led Mental Health Support to Adults Living With Type 1 Diabetes: Co-Design and Development Process.
Lee S, Sidhu B, Johal P, Azhar A, et al · · 2026 · PMID 41861369 · DOI 10.2196/71733

Verify or expand the search:

Other recruiting trials for Type1diabetes

Currently open trials in the same condition.

NCT07139808 — Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System · NA · recruiting
NCT07092761 — Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System · NA · recruiting
NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
NCT06753994 — Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors · Phase 1 · recruiting
NCT06372392 — Universal Fixed Meal Boluses Usage in Patients With Medtronic Minimed 780G Pumps · NA · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05668507 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 13 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05668507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing